BRCA1 and BRCA2: hereditary cancer risk, testing and family next steps
Understand BRCA-related cancer risk, positive and uncertain results, family testing and the questions to discuss with a cancer genetics specialist.
Browse published, medically reviewed explanations. Search a gene, condition or research question, or narrow the collection by topic.
29 articles
Understand BRCA-related cancer risk, positive and uncertain results, family testing and the questions to discuss with a cancer genetics specialist.
Understand Li–Fraumeni syndrome, confirmed TP53 findings, specialist surveillance, family testing and questions to ask before interpreting cancer risk.
Understand Lynch syndrome, tumor versus inherited testing, uncertain results and family screening, with clear questions for a genetics consultation.
Genetic counselling helps people understand information, uncertainty and choices in the context of their own priorities.
Specific diagnoses and ages are more useful than labels such as “it runs in the family.” Incomplete information still matters.
Understand a VUS with practical examples, family-testing questions, ClinVar conflicts and a clear plan for follow-up and possible reclassification.
Understand BRCA2 across inherited cancer risk and tumor testing, including male cancer risks, one versus two affected gene copies and evidence-reading tools.
A practical BRCA1 guide covering DNA repair, germline and tumor findings, uncertain variants, expert evidence and a step-by-step report-reading worksheet.
Understand Lynch syndrome genes, mismatch repair, tumor staining and germline results, with an evidence pathway and practical research checklist.
Understand FAP and attenuated FAP, APC testing, colorectal cancer prevention, ongoing follow-up and practical questions for a hereditary cancer clinic.
Understand FGFR3 gain-of-function, common achondroplasia variants, other gene-associated conditions and the difference between constitutional and tumor findings.
Interpret TP53 results with the specimen, classification and clinical context: constitutional variants, tumor findings, mosaicism and clonal hematopoiesis.